BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22803020)

  • 1. Health state utilities and quality of life in patients with hepatitis B.
    Woo G; Tomlinson G; Yim C; Lilly L; Therapondos G; Wong DK; Ungar WJ; Einarson TR; Sherman M; Heathcote JE; Krahn M
    Can J Gastroenterol; 2012 Jul; 26(7):445-51. PubMed ID: 22803020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life (HRQoL) and health state utilities with chronic hepatitis-B (CHB): A population-based survey in Vietnam.
    Tran QV; Vo TQ
    J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S80-S86. PubMed ID: 31369538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in Thai patients with chronic hepatitis B.
    Chantrakul R; Sripongpun P; Pattarapuntakul T; Chamroonkul N; Kongkamol C; Phisalprapa P; Kaewdech A
    Gastroenterol Rep (Oxf); 2024; 12():goae015. PubMed ID: 38586539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons.
    Levy AR; Kowdley KV; Iloeje U; Tafesse E; Mukherjee J; Gish R; Bzowej N; Briggs AH
    Value Health; 2008; 11(3):527-38. PubMed ID: 18179664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing health-related quality of life and health utilities in patients with chronic hepatitis B-related diseases in China: a cross-sectional study.
    Zhang M; Li Y; Fan Z; Shen D; Huang X; Yu Q; Liu M; Ren F; Wang X; Dai L; Wang P; Ye H; Shi J; Yang X; Zhang S; Zhang J
    BMJ Open; 2021 Sep; 11(9):e047475. PubMed ID: 34526336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-state utilities and quality of life in hepatitis C patients.
    Chong CA; Gulamhussein A; Heathcote EJ; Lilly L; Sherman M; Naglie G; Krahn M
    Am J Gastroenterol; 2003 Mar; 98(3):630-8. PubMed ID: 12650799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life of Southern Chinese with chronic hepatitis B infection.
    Lam ET; Lam CL; Lai CL; Yuen MF; Fong DY; So TM
    Health Qual Life Outcomes; 2009 Jun; 7():52. PubMed ID: 19500349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls.
    Zhuang G; Zhang M; Liu Y; Guo Y; Wu Q; Zhou K; Ji Z; Zhang X
    Health Qual Life Outcomes; 2014 Jun; 12():101. PubMed ID: 24928466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B.
    Kim JH; Kwon SY; Lee YS; Lee JH; Lee YS; Lee CH
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):291-6. PubMed ID: 22019793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis.
    Ju YC; Jun DW; Choi J; Saeed WK; Lee HY; Oh HW
    World J Gastroenterol; 2018 Oct; 24(40):4606-4614. PubMed ID: 30386110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-state utilities in liver disease: a systematic review.
    McLernon DJ; Dillon J; Donnan PT
    Med Decis Making; 2008; 28(4):582-92. PubMed ID: 18424560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    Liu Y; Zhang S; Zhao Y; Du J; Jin G; Shao S; Lu X
    PLoS One; 2016; 11(9):e0162763. PubMed ID: 27631983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does cirrhosis affect quality of life in hepatitis C virus-infected patients?
    Hsu PC; Krajden M; Yoshida EM; Anderson FH; Tomlinson GA; Krahn MD
    Liver Int; 2009 Mar; 29(3):449-58. PubMed ID: 19267865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in chronic hepatitis B patients.
    Ong SC; Mak B; Aung MO; Li SC; Lim SG
    Hepatology; 2008 Apr; 47(4):1108-17. PubMed ID: 18318043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection.
    Hsu PC; Federico CA; Krajden M; Yoshida EM; Bremner KE; Anderson FH; Weiss AA; Krahn MD
    J Gastroenterol Hepatol; 2012 Jan; 27(1):149-57. PubMed ID: 21679248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D.
    Jang ES; Kim YS; Kim KA; Lee YJ; Chung WJ; Kim IH; Lee BS; Jeong SH
    Gut Liver; 2018 Jul; 12(4):440-448. PubMed ID: 29588435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey.
    Karacaer Z; Cakir B; Erdem H; Ugurlu K; Durmus G; Ince NK; Ozturk C; Hasbun R; Batirel A; Yilmaz EM; Bozkurt I; Sunbul M; Aynioglu A; Atilla A; Erbay A; Inci A; Kader C; Tigen ET; Karaahmetoglu G; Coskuner SA; Dik E; Tarakci H; Tosun S; Korkmaz F; Kolgelier S; Karadag FY; Erol S; Turker K; Necan C; Sahin AM; Ergen P; Iskender G; Korkmaz P; Eroglu EG; Durdu Y; Ulug M; Deniz SS; Koc F; Alpat SN; Oztoprak N; Evirgen O; Sozen H; Dogan M; Kaya S; Kaya S; Altindis M; Aslan E; Tekin R; Sezer BE; Ozdemir K; Ersoz G; Sahin A; Celik I; Aydin E; Bastug A; Harman R; Ozkaya HD; Parlak E; Yavuz I; Sacar S; Comoglu S; Yenilmez E; Sirmatel F; Balkan II; Alpay Y; Hatipoglu M; Denk A; Senol G; Bitirgen M; Geyik MF; Guner R; Kadanali A; Karakas A; Namiduru M; Udurgucu H; Boluktas RP; Karagoz E; Ormeci N
    Health Qual Life Outcomes; 2016 Nov; 14(1):153. PubMed ID: 27809934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review.
    Tseng CH; Tseng CM; Wu JL; Hsu YC; El-Serag HB
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1684-1693. PubMed ID: 32343431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
    Papatheodoridis GV; Sypsa V; Dalekos G; Yurdaydin C; van Boemmel F; Buti M; Goulis J; Calleja JL; Chi H; Manolakopoulos S; Loglio A; Siakavellas S; Gatselis N; Keskın O; Lehretz M; Savvidou S; de la Revilla J; Hansen BE; Kourikou A; Vlachogiannakos I; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HLA; Berg T; Lampertico P
    J Hepatol; 2018 Jun; 68(6):1129-1136. PubMed ID: 29427727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.